NVIDIA BioNeMo™ is a generative AI platform for drug discovery that simplifies and accelerates the training of models using your own data and scaling the deployment of models for drug discovery applications. BioNeMo offers the quickest path to both AI model development and deployment, accelerating the journey to AI-powered drug discovery.
Customize and deploy AI models for 3D protein structure prediction, de novo protein and small molecule generation, property predictions, and molecular docking.
Access pretrained models through cloud APIs or an easy-to-use web interface for interactive inference, visualization, and experimentation.
Experience the ultimate flexibility for experimenting and building enterprise-grade generative AI workflows with GUI and API endpoints on scalable, managed infrastructure.
BioNeMo Training is an end-to-end, optimized training service with state-of-the-art models, data loaders, training workflows, validation in the loop, and enterprise support. It's available as an NGC™ container deployable through the NVIDIA Base Command™ Platform for NVIDIA DGX™ Cloud.
BioNeMo cloud APIs allow users to customize and deploy generative AI for drug discovery applications with a user-friendly web interface for rapid evaluation and experimentation while eliminating the need to manage compute infrastructure and maintain complicated software stacks.
NVIDIA DGX Cloud is powered by NVIDIA Base Command Platform, a comprehensive AI workflow management software as a service (SaaS) that spans cloud and on-premises resources. Optimize and train models with the multi-node AI training-as-a-service solution.
Access documentation, tutorials, and community support for BioNeMo.